350 related articles for article (PubMed ID: 18413684)
1. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments.
Dale RA; Jensen LH; Krantz MJ
Ann Pharmacother; 2008 May; 42(5):633-9. PubMed ID: 18413684
[TBL] [Abstract][Full Text] [Related]
2. Comparative performance of two point-of-care analysers for lipid testing.
Shephard MD; Mazzachi BC; Shephard AK
Clin Lab; 2007; 53(9-12):561-6. PubMed ID: 18257461
[TBL] [Abstract][Full Text] [Related]
3. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers.
Whitehead SJ; Ford C; Gama R
Ann Clin Biochem; 2014 Jan; 51(Pt 1):54-67. PubMed ID: 23880620
[TBL] [Abstract][Full Text] [Related]
4. [Precision and accuracy of blood lipid analyses by a portable device (Cholestech-LDX)].
Issa JS; Strunz C; Giannini SD; Forti N; Diament J
Arq Bras Cardiol; 1996 Jun; 66(6):339-42. PubMed ID: 9035449
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Accuracy of 2 Point-of-Care Lipid Testing Devices.
Bastianelli K; Ledin S; Chen J
J Pharm Pract; 2017 Oct; 30(5):490-497. PubMed ID: 27313238
[TBL] [Abstract][Full Text] [Related]
6. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities.
Shemesh T; Rowley KG; Shephard M; Piers LS; O'Dea K
Clin Chim Acta; 2006 May; 367(1-2):69-76. PubMed ID: 16388790
[TBL] [Abstract][Full Text] [Related]
7. The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment.
Whitehead SJ; Ford C; Gama R
J Clin Pathol; 2014 Jun; 67(6):535-9. PubMed ID: 24711512
[TBL] [Abstract][Full Text] [Related]
8. Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids.
Panz VR; Raal FJ; Paiker J; Immelman R; Miles H
Cardiovasc J S Afr; 2005; 16(2):112-7. PubMed ID: 15915279
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of two compact analyzers used for lipid analysis.
McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two point of care devices for capillary lipid screening in fasting and postprandial adults.
Donato LJ; Deobald GR; Wockenfus AM; Hornseth JM; Saenger AK; Karon BS
Clin Biochem; 2015 Feb; 48(3):174-6. PubMed ID: 25448034
[TBL] [Abstract][Full Text] [Related]
11. [A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids].
Ose L; Aass B; Christophersen B
Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3487-9. PubMed ID: 7491599
[TBL] [Abstract][Full Text] [Related]
12. [Standardization of the methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia].
Grafnetter D; Feruglio GA; Vanuzzo D
G Ital Cardiol; 1996 Mar; 26(3):287-97. PubMed ID: 8690184
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlation between a point-of-care testing system and laboratory automation for lipid profile.
Ferreira CE; França CN; Correr CJ; Zucker ML; Andriolo A; Scartezini M
Clin Chim Acta; 2015 Jun; 446():263-6. PubMed ID: 25952166
[TBL] [Abstract][Full Text] [Related]
14. Validation of a point of care lipid analyser using a hospital based reference laboratory.
Carey M; Markham C; Gaffney P; Boran C; Maher V
Ir J Med Sci; 2006; 175(4):30-5. PubMed ID: 17312826
[TBL] [Abstract][Full Text] [Related]
15. Assessing the accuracy of a point-of-care analyzer for hyperlipidaemia in western Kenya.
Park PH; Chege P; Hagedorn IC; Kwena A; Bloomfield GS; Pastakia SD
Trop Med Int Health; 2016 Mar; 21(3):437-44. PubMed ID: 26663749
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of lipid profile measurements obtained from the Cholestech L.D.X analyzer.
Bard RL; Kaminsky LA; Whaley MH; Zajakowski S
J Cardiopulm Rehabil; 1997; 17(6):413-8. PubMed ID: 9421763
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Cholestech L.D.X. desktop analyser for cholesterol, HDL-cholesterol, and triacylglycerols in heparinized venous blood.
Cobbaert C; Boerma GJ; Lindemans J
Eur J Clin Chem Clin Biochem; 1994 May; 32(5):391-4. PubMed ID: 8086524
[TBL] [Abstract][Full Text] [Related]
19. Analytic and clinical performance of two compact cholesterol-testing devices.
Volles DF; McKenney JM; Miller WG; Ruffen D; Zhang D
Pharmacotherapy; 1998; 18(1):184-92. PubMed ID: 9469692
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
